KPMA Chairman Make Suggestions to Government’s R&D Investment Policy

Published: 2004-12-21 07:00:00

Updated: 2004-12-21 07:00:00

In his recent contributing article to the JoongAng Daily, Chairman Kim Jung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) stated the importance of promoting an efficient R&D investment by the government to foster the development of new medicines.

Chairman Kim Jung-soo mentioned in the article that China is becoming the Asia’s central hub for new medicine development, as ma...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.